HPV DNA testing in cervical cancer screening: From evidence to policies

This publication has 24 references indexed in Scilit:

• Predicting absolute risk of CIN3 during post-colposcopic follow-up: Results from the ASCUS-LSIL Triage Study (ALTS)
  American Journal of Obstetrics and Gynecology, 2006
• Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled Trial
  JNCI Journal of the National Cancer Institute, 2006
• Overview of the European and North American studies on HPV testing in primary cervical cancer screening
  International Journal of Cancer, 2006
• Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting
  British Journal of Cancer, 2005
• Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence
  American Journal of Obstetrics and Gynecology, 2005
• The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice
  JNCI Journal of the National Cancer Institute, 2005
• Human Papillomavirus Type 16 Infections and 2-Year Absolute Risk of Cervical Precancer in Women With Equivocal or Mild Cytologic Abnormalities
  JNCI Journal of the National Cancer Institute, 2005
• Cost-effectiveness of Human Papillomavirus DNA Testing in the United Kingdom, The Netherlands, France, and Italy
  JNCI Journal of the National Cancer Institute, 2005
• Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial Neoplasia
  JNCI Journal of the National Cancer Institute, 2004
• Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening
  Obstetrics & Gynecology, 2004